ICICI Pru Nfty Phrm Idx Gr
What This Strategy Does
CW Expert Research Notes
Consistent Outperformance
The fund has demonstrated resilient benchmark-relative behavior, outperforming in 10 of the past 12 years, highlighting its ability to deliver consistent earnings participation and downside protection across market cycles.
Concentrated Healthcare Exposure
With a 100% allocation to the healthcare sector, the fund's investment process expresses high conviction in pharmaceutical and biotech companies like Sun Pharma and Dr. Reddy's, capitalizing on structural growth trends in the Indian healthcare market.
Defensive Portfolio Characteristics
Exhibiting a low beta of 0.8 and attractive Sharpe ratio of 0.85, the fund's risk behavior suggests it could serve as a defensive, non-cyclical portfolio holding, though its narrow sector focus presents idiosyncratic risks if the healthcare thesis falters.
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Fund Performance
Benchmark Performance Comparison
Risk Profile
Detailed Risks
Market Risk
Recession fears amid slowing global growth could trigger demand contraction for pharmaceuticals, mitigated by defensive sector positioning.
Liquidity Risk
Concentrated mid-cap exposure could amplify liquidity stress during volatility spikes, mitigated by large-cap tilt.
Concentration Risk
Significant sector concentration in pharmaceuticals exposes fund to regulatory pricing pressures, mitigated by diversification across multiple holdings.
Specific Strategy Risk
Competitive dynamics and patent cliffs could pressure earnings for key pharmaceutical holdings, mitigated by active monitoring.
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Core Investment Theme
Provides targeted exposure to India's pharmaceutical and healthcare companies—sectors poised for long-term growth driven by rising incomes, lifestyle diseases, and an aging population. This theme captures the secular tailwinds propelling India's healthcare industry.
Broader Market View
Market Outlook
Why This Strategy is Attractive Now
Investment Style & Process
Investment Style
Why it Makes Sense
High-Level Investment Process
Portfolio Holdings Overview
Geographic Allocation
Top Stock Holdings
Fund House Management
The asset management company’s track record, AUM scale, and fund manager credentials.
Fund Manager Track Record
Ashwini Bharucha
Lead Portfolio Manager
Ashwini Bharucha has experience of 2 years. Manages 218 funds at ICICI Prudential Asset Management Co Ltd with an AUM of approximately ₹94 Cr
Nishit Patel
Co-Portfolio ManagerMr. Nishit Patel has experience of 9 years. Manages 228 funds at ICICI Prudential Asset Management Co Ltd with an AUM of approximately ₹94 Cr Holds a B.Com degree.
CW Expert Take
ICICI Prudential combines scale with specialization. Their investment philosophy centers on understanding business economics rather than following market momentum. The fund house has built distinct expertise across asset classes, from equity research teams focused on sectoral deep-dives to fixed income desks with strong credit assessment capabilities.
11 years
Combined Team Experience
₹ 188 Cr
Assets Under Management
Firm Overview
Investment Philosophy & Approach
Disciplined Indexing
The fund employs a passive strategy to replicate the performance of the underlying index.
Sector Specialization
The fund focuses exclusively on the pharmaceutical sector, providing targeted exposure.
Cost-Efficiency
The fund aims to minimize tracking error while keeping costs low.
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Regulatory & Tax Information
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)